Literature DB >> 3089520

Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.

J Adams, D W Polson, S Franks.   

Abstract

Polycystic ovaries were defined with ultrasound imaging in a series of 173 women who presented to a gynaecological endocrine clinic with anovulation or hirsutism. Polycystic ovaries were found in 26% of women with amenorrhoea, 87% with oligomenorrhoea, and 92% with idiopathic hirsutism--that is, hirsutism but with regular menstrual cycles. Fewer than half the anovulatory patients with polycystic ovaries were hirsute, but in 93% of cases there was at least one endocrine abnormality to support the diagnosis of polycystic ovaries--that is, raised serum concentrations of luteinising hormone, raised luteinising hormone: follicle stimulating hormone ratio, or raised serum concentrations of testosterone or androstenedione. This study shows that polycystic ovaries, as defined by pelvic ultrasound, are very common in anovulatory women (57% of cases) and are not necessarily associated with hirsutism or a raised serum luteinising hormone concentration. Most women with hirsutism and regular menses have polycystic ovaries so that the term "idiopathic" hirsutism no longer seems appropriate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089520      PMCID: PMC1341046          DOI: 10.1136/bmj.293.6543.355

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  8 in total

1.  Clinical assessment of body hair growth in women.

Authors:  D FERRIMAN; J D GALLWEY
Journal:  J Clin Endocrinol Metab       Date:  1961-11       Impact factor: 5.958

2.  The polycystic ovary. I. Clinical and histologic features.

Authors:  J W GOLDZIEHER; J A GREEN
Journal:  J Clin Endocrinol Metab       Date:  1962-03       Impact factor: 5.958

3.  Polycystic-ovary syndrome--what is it?

Authors:  J L Vaitukaitis
Journal:  N Engl J Med       Date:  1983-11-17       Impact factor: 91.245

Review 4.  The polycystic ovary syndrome.

Authors:  S S Yen
Journal:  Clin Endocrinol (Oxf)       Date:  1980-02       Impact factor: 3.478

5.  Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone.

Authors:  J Adams; S Franks; D W Polson; H D Mason; N Abdulwahid; M Tucker; D V Morris; J Price; H S Jacobs
Journal:  Lancet       Date:  1985 Dec 21-28       Impact factor: 79.321

6.  Oestrogen amplification of LH-RH response in the polycystic ovary syndrome and response to clomiphene.

Authors:  F R Kandeel; W R Butt; D R London; S S Lynch; R L Edwards; B T Rudd
Journal:  Clin Endocrinol (Oxf)       Date:  1978-11       Impact factor: 3.478

7.  The role of ultrasound in the study of polycystic ovarian disease.

Authors:  L Parisi; M Tramonti; S Casciano; A Zurli; O Gazzarrini
Journal:  J Clin Ultrasound       Date:  1982-04       Impact factor: 0.910

Review 8.  Ovulatory disorders in women with polycystic ovary syndrome.

Authors:  S Franks; J Adams; H Mason; D Polson
Journal:  Clin Obstet Gynaecol       Date:  1985-09
  8 in total
  108 in total

1.  Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.

Authors:  Susan Sam; Richard S Legro; Paulina A Essah; Teimuraz Apridonidze; Andrea Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

Review 2.  Genetics of ovarian disorders: polycystic ovary syndrome.

Authors:  Stephen Franks; Mark McCarthy
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

3.  Hirsutism.

Authors:  G S Conway; H S Jacobs
Journal:  BMJ       Date:  1990-09-29

4.  Polycystic ovaries and polycystic ovary syndrome in epilepsy: evidence for neurogonadal disease.

Authors:  Cynthia L Harden
Journal:  Epilepsy Curr       Date:  2005 Jul-Aug       Impact factor: 7.500

Review 5.  ACP Broadsheet 131: March 1992. Hirsute women: should they be investigated?

Authors:  J H Barth
Journal:  J Clin Pathol       Date:  1992-03       Impact factor: 3.411

6.  GH-IGF-I axis in non-obese women with functional hyperandrogenism.

Authors:  M Legan; A Kocijancic; J Prezelj; J Osredkar; S Fisker
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

7.  Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients.

Authors:  J Balasch; F Fábregues; J Peñarrubia; M Creus; R Vidal; R Casamitjana; D Manau; J A Vanrell
Journal:  J Assist Reprod Genet       Date:  1998-10       Impact factor: 3.412

Review 8.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

9.  Growth-hormone response to combined stimulation with GHRH plus GH-releasing peptide-6 in obese patients with polycystic ovary syndrome before and after short-term fasting.

Authors:  D Micić; M Sumarac-Dumanović; Dj Macut; A Kendereski; S Zoric; V Popović; G Cvijović; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

Review 10.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.